These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 1531022

  • 21. Plasmin-Induced Activation of Human Platelets Is Modulated by Thrombospondin-1, Bona Fide Misfolded Proteins and Thiol Isomerases.
    Pielsticker C, Brodde MF, Raum L, Jurk K, Kehrel BE.
    Int J Mol Sci; 2020 Nov 23; 21(22):. PubMed ID: 33238433
    [Abstract] [Full Text] [Related]

  • 22. Poly-L-histidine downregulates fibrinolysis.
    Chu AJ, Mathews ST.
    Blood Coagul Fibrinolysis; 2003 Oct 23; 14(7):627-32. PubMed ID: 14517486
    [Abstract] [Full Text] [Related]

  • 23. Platelet thrombospondin forms a trimolecular complex with plasminogen and histidine-rich glycoprotein.
    Silverstein RL, Leung LL, Harpel PC, Nachman RL.
    J Clin Invest; 1985 Jun 23; 75(6):2065-73. PubMed ID: 4008652
    [Abstract] [Full Text] [Related]

  • 24. Fibrinolysis with des-kringle derivatives of plasmin and its modulation by plasma protease inhibitors.
    Komorowicz E, Kolev K, Machovich R.
    Biochemistry; 1998 Jun 23; 37(25):9112-8. PubMed ID: 9636057
    [Abstract] [Full Text] [Related]

  • 25. Decoy plasminogen receptor containing a selective Kunitz-inhibitory domain.
    Kumar Y, Vadivel K, Schmidt AE, Ogueli GI, Ponnuraj SM, Rannulu N, Loo JA, Bajaj MS, Bajaj SP.
    Biochemistry; 2014 Jan 28; 53(3):505-17. PubMed ID: 24383758
    [Abstract] [Full Text] [Related]

  • 26. The cowpox virus serpin SPI-3 complexes with and inhibits urokinase-type and tissue-type plasminogen activators and plasmin.
    Turner PC, Baquero MT, Yuan S, Thoennes SR, Moyer RW.
    Virology; 2000 Jul 05; 272(2):267-80. PubMed ID: 10873770
    [Abstract] [Full Text] [Related]

  • 27. Fibrinolysis--a review.
    Kane KK.
    Ann Clin Lab Sci; 1984 Jul 05; 14(6):443-9. PubMed ID: 6239587
    [Abstract] [Full Text] [Related]

  • 28. Characterization of the binding of thrombospondin to human platelets and its association with the platelet cytoskeleton.
    Dubernard V, Legrand C.
    J Lab Clin Med; 1991 Nov 05; 118(5):446-57. PubMed ID: 1940585
    [Abstract] [Full Text] [Related]

  • 29. Homocysteine and its thiolactone impair plasmin activity induced by urokinase or streptokinase in vitro.
    Kolodziejczyk-Czepas J, Talar B, Nowak P, Olas B, Wachowicz B.
    Int J Biol Macromol; 2012 Apr 01; 50(3):754-8. PubMed ID: 22197896
    [Abstract] [Full Text] [Related]

  • 30. Oxidative inactivation of plasmin and other serine proteases by copper and ascorbate.
    Lind SE, McDonagh JR, Smith CJ.
    Blood; 1993 Sep 01; 82(5):1522-31. PubMed ID: 8364203
    [Abstract] [Full Text] [Related]

  • 31. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
    Glas-Greenwalt P, Kant KS, Allen C, Pollak VE.
    J Lab Clin Med; 1984 Dec 01; 104(6):962-76. PubMed ID: 6239000
    [Abstract] [Full Text] [Related]

  • 32. Catabolic pathways for streptokinase, plasmin, and streptokinase activator complex in mice. In vivo reaction of plasminogen activator with alpha 2-macroglobulin.
    Gonias SL, Einarsson M, Pizzo SV.
    J Clin Invest; 1982 Aug 01; 70(2):412-23. PubMed ID: 6178757
    [Abstract] [Full Text] [Related]

  • 33. Regulation of the activities of thrombin and plasmin by cholesterol sulfate as a physiological inhibitor in human plasma.
    Iwamori M, Iwamori Y, Ito N.
    J Biochem; 1999 Mar 01; 125(3):594-601. PubMed ID: 10050049
    [Abstract] [Full Text] [Related]

  • 34. [Degradation of streptokinase and the catalytic properties of the plasmin-streptokinase complex].
    Hrynenko TV, Makohonenko IeM, Iusova OI, Cederholm-Williams SA.
    Ukr Biokhim Zh (1999); 2002 Mar 01; 74(3):50-7. PubMed ID: 12916237
    [Abstract] [Full Text] [Related]

  • 35. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH, Diamond SL.
    Thromb Haemost; 1995 Aug 01; 74(2):711-7. PubMed ID: 8585011
    [Abstract] [Full Text] [Related]

  • 36. Extrinsic plasminogen activator: a new principle in fibrinolysis.
    Lijnen HR.
    Behring Inst Mitt; 1983 Aug 01; (73):43-55. PubMed ID: 6236789
    [Abstract] [Full Text] [Related]

  • 37. Fibrinolysis and fibrinogenolysis by Val442-plasmin.
    Ney KA, Pizzo SV.
    Biochim Biophys Acta; 1982 Nov 09; 708(2):218-24. PubMed ID: 6216916
    [Abstract] [Full Text] [Related]

  • 38. The release of heparin binding peptides from platelet thrombospondin by proteolytic action of thrombin, plasmin and trypsin.
    Lawler JW, Slayter HS.
    Thromb Res; 1981 May 01; 22(3):267-79. PubMed ID: 6458114
    [No Abstract] [Full Text] [Related]

  • 39. Regulation of fibrinolysis by C-terminal lysines operates through plasminogen and plasmin but not tissue-type plasminogen activator.
    Silva MM, Thelwell C, Williams SC, Longstaff C.
    J Thromb Haemost; 2012 Nov 01; 10(11):2354-60. PubMed ID: 22974122
    [Abstract] [Full Text] [Related]

  • 40. Plasminogen assay by means of the lysis time method.
    Berg W, Korsan-Bengtsen K, Ygge J.
    Thromb Diath Haemorrh; 1965 Sep 01; 14(1-2):127-44. PubMed ID: 16955971
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.